Absci is a biotechnology company that combines artificial intelligence with synthetic biology for protein discovery and cell line development. The organization employs about 172 people and recently recorded an equal number of hires and departures, resulting in a steady overall headcount. This balanced growth suggests a measured approach to scaling while the company advances its scientific platform.
Engineering is the largest group with 98 employees, representing well over half of the company’s workforce and underscoring Absci’s research-driven focus. Business Management (22 employees) and Finance & Administration (15) provide commercial and operational support, while scientific and technical roles such as Healthcare (10) and Information Technology (6) contribute to product development and infrastructure. Smaller teams in Legal, Program & Project Management, Human Resources, Operations, and a catch-all Other category round out the organization, indicating a lean but comprehensive departmental structure.
Absci’s talent base is concentrated in the Pacific Northwest, with 49 employees in Vancouver, Washington and 44 in nearby Portland, Oregon. Additional clusters are spread across key U.S. biotech hubs, including Boston, San Diego, Seattle, San Francisco, and New York, each hosting between 3 and 8 employees. A further 47 staff members work remotely or in miscellaneous locations, providing geographic flexibility without a heavy reliance on any single satellite office.